BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• 

  Immunology and inflammation

  AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical

  In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered symptom burden in patients with chronic obstructive pulmonary disorder.

  July 8, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  IPO

  Obesity newcomer Kalohexis makes confidential IPO bid 3 months after spinoff

  Kalohexis is working on peptide therapies, including one for obesity that could offer an alternative approach to the GLP-1s that currently dominate the weight loss space.

  July 8, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247

  July 8, 2026

   · 

  11 min read
• Press Releases

  Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

  July 8, 2026

   · 

  5 min read
• Press Releases

  Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors

  July 8, 2026

   · 

  6 min read
• Press Releases

  Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

  July 8, 2026

   · 

  6 min read
• Press Releases

  OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain

  July 8, 2026

   · 

  4 min read
• Press Releases

  Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

  July 8, 2026

   · 

  13 min read
• Press Releases

  Moderna Appoints Michael McDonnell to Board of Directors

  July 8, 2026

   · 

  4 min read
• Press Releases

  Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis

  July 8, 2026

   · 

  6 min read